| Literature DB >> 23453067 |
Claire Bourdin1, Christopher McGuigan, Andrea Brancale, Stanley Chamberlain, John Vernachio, Jeff Hutchins, Elena Gorovits, Alexander Kolykhalov, Jerry Muhammad, Joseph Patti, Geoffrey Henson, Blair Bleiman, K Dawn Bryant, Babita Ganguly, Damound Hunley, Aleksandr Obikhod, C Robin Walters, Jin Wang, Changalvala V S Ramamurty, Srinivas K Battina, C Srivinas Rao.
Abstract
7-Deazapurines are known to possess broad antiviral activity, however the 2'-C-methylguanosine analogue displays poor cell permeation and limited phosphorylation, thus is not an efficient inhibitor of hepatitis C virus (HCV) replication. We previously reported the 6-O-methyl entity as a prodrug moiety to increase liphophilicity of guanine nucleosides and the ProTide approach applied to 2'-C-methyl-6-O-methylguanosine has lead to potent HCV inhibitors now in clinical trials. In this Letter, we report the synthesis and biological evaluation of 2'-C-methyl-6-O-methyl-7-deaza guanosine and ProTide derivatives. In contrast to prior studies, removal of the N-7 of the nucleobase entirely negates anti-HCV activity compared to the 2'-C-methyl-6-O-methylguanosine analogues. To understand better this significant loss of activity, enzymatic assays and molecular modeling were carried out and suggested 2'-C-methyl-6-O-methyl-7-deaza guanosine and related ProTides do not act as efficient prodrugs of the free nucleotide, in marked contrast to the case of the parent guanine analogue.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23453067 DOI: 10.1016/j.bmcl.2012.12.004
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823